CureSHANK Logo (IMAGE)
Caption
Parents of children affected by Phelan-McDermid syndrome (PMS) announce CureSHANK, a nonprofit organization focused on accelerating drug development in PMS and other diseases related to the SHANK genes for which there are currently no FDA approved treatments. As one of a small handful of known monogenic causes of autism, PMS presents an excellent launch pod to develop disease-modifying therapies not only for the syndrome but also for other SHANK related diseases and forms of autism.
Credit
CureSHANK Inc.
Usage Restrictions
None
License
Licensed content